Eva Zuvich

Discovery of (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a selective, orally active agonist of the 5-HT(2C) receptor.

E. Janovitz, L. Lehman-Mckeeman, Xueying Cao, 2007, Journal of medicinal chemistry.

Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice.

Karla K Kopec, J. Salvino, D. Flood, 2010, Biochemical pharmacology.

Reductions in log P improved protein binding and clearance predictions enabling the prospective design of cannabinoid receptor (CB1) antagonists with desired pharmacokinetic properties.

K. Behnia, N. Murugesan, Z. Gu, 2013, Journal of medicinal chemistry.

Prepulse inhibition of the startle reflex and response to antipsychotic treatments in two outbred mouse strains in comparison to the inbred DBA/2 mouse

D. Flood, M. Gasior, M. Marino, 2011, Psychopharmacology.

A Mouse Model of Furosemide‐Induced Overactive Bladder

M. Saporito, A. Dicamillo, Eva Zuvich, 2016, Current protocols in pharmacology.